| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.26 | 1e-06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-06 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-06 |